We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04144036
Recruitment Status : Recruiting
First Posted : October 30, 2019
Last Update Posted : October 10, 2022
Sponsor:
Information provided by (Responsible Party):
Sameem M. Abedin, MD, Medical College of Wisconsin

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 1, 2023
Estimated Study Completion Date : December 1, 2023